SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants.
Rodriguez L, Lee HW, Li J, Martin R, Han D, Xu S, Moshiri J, Peinovich N, Camus G, Perry JK, Hyland RH, Porter DP, Abdelghany M, Götte M, Hedskog C.
Rodriguez L, et al. Among authors: lee hw.
Antimicrob Agents Chemother. 2024 Dec 19:e0123824. doi: 10.1128/aac.01238-24. Online ahead of print.
Antimicrob Agents Chemother. 2024.
PMID: 39699245
Free article.